---
id: 2025-12-24_004
title: "Challenge trial unit needs research - vaccine program & Houghton"
type: text
status: incorporated
incorporated: 2025-12-25T01:10:00Z
incorporated_in:
  - suites/suite_1_clinical_trials_infrastructure.md
  - rta/rta.md
  - briefs/suite_1_brief.md
  - includes/suite_1_description.md
priority: high
created: 2025-12-24T18:12:50Z
reviewed: 2025-12-24T19:30:00Z
links:
  documents:
    - suites/suite_1_clinical_trials_infrastructure.md
  objectives: [1, 2]
  suites: [1]
tags:
  - challenge-trial
  - vaccine
  - Houghton
  - Nobel
  - infrastructure
  - IMPLEMENTED
---

# Idea

Developing a concept challenge trial unit I do not think has been fully fleshed out with a thorough web search and requirements identification. This component of the clinical trial infrastructure is critical to the vaccine program and should include Michael Houghton's work as a Nobel laureate.

## Status: IMPLEMENTED

This idea has been researched and implemented. See changes below.

## Research Conducted

Comprehensive web research was performed on:

1. **International Challenge Trial Facilities**
   - hVIVO (UK/Germany): 150+ beds, BSL-3 certified, world's largest commercial operator
   - Imperial College London: Led world's first COVID-19 challenge study (2021)
   - Royal Free Hospital: Specialist secure containment unit
   - Chelsea & Westminster Hospital: Ron Johnson Ward quarantine unit

2. **Facility Design Requirements**
   - Negative pressure: -25 to -30 Pa (10x CDC minimum)
   - Air changes: â‰¥10-12 ACH with HEPA filtration
   - Room configuration: En-suite bathroom, airlock entry, interlocking doors
   - Monitoring: 24/7 medical staff, telemetry, video surveillance
   - Quarantine duration: 14+ days typical, PCR-negative discharge

3. **Regulatory Pathway**
   - Health Canada: Standard CTA process (no specific CHIM guidance)
   - WHO Guidance: TRS 1004, Annex 10
   - ICH E6(R2) Good Clinical Practice
   - Pre-submission meeting recommended for novel protocols

4. **Canada's Gap**
   - NO dedicated challenge trial facilities exist in Canada
   - CTAP would establish Canada's first academic capability

## Implementation Completed

### Suite 1 Document Updates
- Added Section 1.5: Vaccine Challenge Trial Unit ($490,000)
- Added extensive Section 2: Challenge Trial Unit Background & Rationale
  - 2.1 What are Human Challenge Trials?
  - 2.2 International Exemplars and Standards
  - 2.3 Facility Design Requirements
  - 2.4 Regulatory Pathway
  - 2.5 Michael Houghton and Li Ka Shing Institute Integration
  - 2.6 Strategic Value
- Updated budget from $1,700,000 to $2,190,000

### Google Sheets Updates
- Added 4 equipment items to Equipment tab (IDs 38-41)
- Updated Michael Houghton entry in Participants tab with full credentials

### RTA Updates
- Enhanced Hepatitis C and Vaccine Trials flagship program section
- Added Michael Houghton (Nobel laureate 2020) as program lead
- Added Challenge Trial Unit as key capability

### Brief and Include Updates
- Updated Suite 1 brief with challenge trial capability
- Updated includes/suite_1_description.md

## Key References

- [hVIVO Human Challenge Models](https://hvivo.com/human-challenge-models/)
- [Imperial College Human Challenge Studies](https://www.imperial.ac.uk/infectious-disease/research/human-challenge/)
- [WHO Human Challenge Trials Guidance (TRS 1004)](https://www.who.int/publications/m/item/human-challenge-trials-for-vaccine-a10-trs-no-1004)
- [Health Canada Clinical Trial Applications](https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/clinical-trials/clinical-trial-sponsors-applications.html)
- [Michael Houghton Nobel Prize](https://www.ualberta.ca/en/michael-houghton-nobel-prize-2020.html)
- [Li Ka Shing Applied Virology Institute](https://www.ualberta.ca/en/li-ka-shing-institute-virology/li-ka-shing-applied-virology-institute/about-avi/director.html)
- [UK Challenge Trials Infrastructure Analysis](https://ukdayone.org/briefings/making-the-uk-the-global-centre-for-challenge-trials)

## Equipment Added ($490,000 total)

| Component | Quantity | Cost |
|-----------|----------|------|
| Challenge isolation rooms | 4 | $300,000 |
| HEPA filtration upgrade | 4 | $80,000 |
| Continuous monitoring stations | 4 | $60,000 |
| Pathogen preparation area | 1 | $50,000 |
